Joseph Ohayon has over 20 years of experience in financial roles, including 10 years within health related industries. Mr Ohayon qualified as a Chartered Accountant in the UK and graduated with a Masters of Business Administration in International Business from Murdoch University.
|
REMUNERATION UPDATE: Chief Financial Officer, Company Secretary since 2011, Arovella Therapeutics | 02 Nov 2020 |
| Position | Company | Year | Company's current rank |
|---|---|---|---|
Chief Financial Officer, Company Secretary since 2011
|
2010 - 2020 | ||
Executive Director
|
2012 - 2019 | ||
Manager, Corporate Planning
|
2007 - 2009 |
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| 2018-08-02 | Sold | 40,000 | $1.06 | $42,333 | Other | |
| 2018-08-02 | Issued | 4,806,667 | $0.00 | $24,033 | Other | |
| 2018-08-02 | Issued | 2,403,333 | $0.00 | Other | ||
| 2018-06-29 | Bought | 20,000 | $1.00 | $20,000 | Other | |
| 2017-12-11 | Issued | 4,000,000 | $0.00 | Other |
